Generation Bio

$32.75
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.88 (-5.43%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Generation Bio and other stocks, options, and ETFs commission-free!

About GBIO

Generation Bio Co. Common Stock, also called Generation Bio, is a genetic medicines company focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. Its non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company was founded by Mark D. Angelino, Jason P. Rhodes, and Robert M. Kotin in 2016 and is headquartered in Cambridge, MA. The listed name for GBIO is Generation Bio Co. Common Stock.

CEO
Cameron Geoffrey McDonough
Employees
85
Headquarters
Cambridge, Massachusetts
Founded
2016
Market Cap
2.06B
Price-Earnings Ratio
Dividend Yield
Average Volume
427.66K
High Today
$35.77
Low Today
$29.23
Open Price
$35.58
Volume
569.46K
52 Week High
$55.72
52 Week Low
$17.00

GBIO Earnings

-$1.50
-$1.00
-$0.50
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 10, Pre-Market

You May Also Like

FXG
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure